Search

Your search keyword '"Kathy Astrahantseff"' showing total 30 results

Search Constraints

Start Over You searched for: Author "Kathy Astrahantseff" Remove constraint Author: "Kathy Astrahantseff" Publication Year Range Last 10 years Remove constraint Publication Year Range: Last 10 years
30 results on '"Kathy Astrahantseff"'

Search Results

1. Inhibiting H3K27 Demethylases Downregulates CREB‐CREBBP, Overcoming Resistance in Relapsed Acute Lymphoblastic Leukemia

2. A MYCN-driven de-differentiation profile identifies a subgroup of aggressive retinoblastoma

Catalog

Books, media, physical & digital resources

3. Author Correction: A MYCN-driven de-differentiation profile identifies a subgroup of aggressive retinoblastoma

4. Defining the landscape of circular RNAs in neuroblastoma unveils a global suppressive function of MYCN

5. Spatial and temporal intratumour heterogeneity has potential consequences for single biopsy-based neuroblastoma treatment decisions

6. Inhibiting PHGDH with NCT-503 reroutes glucose-derived carbons into the TCA cycle, independently of its on-target effect

7. GD2-directed bispecific trifunctional antibody outperforms dinutuximab beta in a murine model for aggressive metastasized neuroblastoma

8. A Reproducible Bioprinted 3D Tumor Model Serves as a Preselection Tool for CAR T Cell Therapy Optimization

9. A Deep Dive into the Circulating ctDNA Cosmos to Vanquish Neuroblastoma

10. Supplementary Figure from Targeted Analysis of Cell-free Circulating Tumor DNA is Suitable for Early Relapse and Actionable Target Detection in Patients with Neuroblastoma

11. Supplementary Data from Targeted Analysis of Cell-free Circulating Tumor DNA is Suitable for Early Relapse and Actionable Target Detection in Patients with Neuroblastoma

12. Data from Targeted Analysis of Cell-free Circulating Tumor DNA is Suitable for Early Relapse and Actionable Target Detection in Patients with Neuroblastoma

13. Inhibiting casein kinase 2 sensitizes acute lymphoblastic leukemia cells to venetoclax via MCL1 degradation

14. Multiplexed Quantification of Four Neuroblastoma DNA Targets in a Single Droplet Digital PCR Reaction

15. Subclonal NT5C2 mutations are associated with poor outcomes after relapse of pediatric acute lymphoblastic leukemia

16. Circulating Cell-Free DNA Assessment in Biofluids from Children with Neuroblastoma Demonstrates Feasibility and Potential for Minimally Invasive Molecular Diagnostics

17. Targeted Analysis of Cell-free Circulating Tumor DNA is Suitable for Early Relapse and Actionable Target Detection in Patients with Neuroblastoma

18. Inhibiting Lysine Demethylase 1A Improves L1CAM-Specific CAR T Cell Therapy by Unleashing Antigen-Independent Killing via the FAS-FASL Axis

19. Improving Stratification for Children With Late Bone Marrow B-Cell Acute Lymphoblastic Leukemia Relapses With Refined Response Classification and Integration of Genetics

20. Inhibiting PHGDH with NCT-503 reroutes glucose-derived carbons into the TCA cycle, independently of its on-target effect

21. Discovery of Spatial Peptide Signatures for Neuroblastoma Risk Assessment by MALDI Mass Spectrometry Imaging

22. Central memory phenotype drives success of checkpoint inhibition in combination with CAR T cells

23. Correction to: The pitfalls and promise of liquid biopsies for diagnosing and treating solid tumors in children: as review

24. 2017 GPOH Empfehlungen für Diagnostik und Therapie von Patienten mit neuroblastischen Tumoren

25. Incidence of second cancers after radiotherapy and systemic chemotherapy in heritable retinoblastoma survivors: A report from the German reference center

26. Rational Response-Adapted Risk Stratification and Treatment for Children with Late Bone Marrow Relapses of B-Cell Precursor Acute Lymphoblastic Leukaemia: A Report from the ALL-REZ BFM Trial Group

27. Mutational dynamics between primary and relapse neuroblastomas

28. The GSK461364 PLK1 inhibitor exhibits strong antitumoral activity in preclinical neuroblastoma models

29. MYCN and HDAC5 transcriptionally repress CD9 to trigger invasion and metastasis in neuroblastoma

30. Abstract 5679: Using droplet digital PCR to analyze MYCN copy number in plasma from patients with high-risk neuroblastoma